Asymptomatic severe aortic stenosis: Will these trials change my practice?

With the collaboration of Partners in Learning - a PCR/CRF Collaboration

SHOW MORE

Summary

This session, in collaboration with Partners in Learning, explores the emerging evidence on the use of transcatheter aortic valve implantation (TAVI) in patients with asymptomatic severe aortic stenosis. It covers data from registries and randomized controlled trials, the current guideline recommendations, and the potential impact of ongoing trials on clinical practice. The discussions aim to help participants synthesize and interpret this information in the context of their daily clinical practice.

Learning Objectives

  • To hear more about the emerging evidence concerning the use of TAVI in asymptomatic severe aortic stenosis
  • To understand how to synthesise and interpret this information in clinical context
  • To translate this understanding into your heart team\'s daily clinical practice

Presentations available when logged in:

  • Introduction
  • Data coming from registries indicating the associates of poor outcomes for patients with asymptomatic severe aortic stenosis
  • Data coming from RCT showing the efficacy of intervention versus medical therapy in patients with asymptomatic severe aortic stenosis
  • What do guidelines say?
  • Overview of ongoing trials
  • Randomised clinical trials: focus on imaging
  • Randomised clinical trials: focus on imaging
  • Will the guidelines change?